WE43310-header5


Even in these unprecedented times research, learning, and knowledge exchange in precision oncology research must continue, just as routine patient testing and treatment must.


 

Thank you for visiting our booth at ESP/IAP 2020 Virtual Congress

If you did not have a chance to visit our booth or symposium or would like access to the scientific talks presented at the conference, here is an opportunity to download all the information you need.

Advancing precision oncology requires effective biomarker testing and actionable insights that drive better patient outcomes in the future. With next-generation sequencing (NGS), you can now get the insights you need when you need them—in one day not weeks. Learn more about thought leaders experiences.

It's NGS, as fast and easy as IHC or PCR

The Oncomine Precision Assay on the Ion Torrent Genexus System features a complete next-generation sequencing (NGS) testing workflow. Now every lab can go from specimen to report in a single day, providing a comprehensive genomic profile at a speed never possible before. This allows you to deliver NGS results at the same time as other single-gene methods, such as immunohistochemistry (IHC) and PDL1 biomarker test. The hands-off, set-up-and-go workflow makes NGS accessible, even if your lab is new to the technology.



Oncomine World Autumn

A virtual NGS education meeting

OncomineWorld Autumn on demand is now available, we present you with an all-new opportunity to learn about the latest developments in cancer genomic profiling.

Catch up on presentations and discussions about new ESMO NGS guidelines, new biomarkers such as homologous recombination deficiency (HRD), and much more.

Participants will also have the opportunity to watch demonstrations of the Ion Torrent Genexus System from a Thermo Fisher Scientific lab, and hear from users about their experiences with the Ion Torrent Oncomine Precision Assay and Ion Torrent Oncomine Myeloid Assay GX.

We hope you will enjoy and benefit from this meeting.

Join on demand

 
ESMO Virtual Congress 2020

NGS biomarker testing: time matters—No longer need to wait for weeks, this now can happen in days

Watch the ESMO symposium now on demand.

Introduction: genomic profiling is driving precision oncology 

Philip Jermann
UNI Hospital, Basel, Switzerland

Gabriela Fernandes, MD
Pulmonology Department, Centro Hospitalar, Universitário de São João, Alameda Prof. Hernâni Monteiro, Portugal

Philip Jermann
UNI Hospital, Basel, Switzerland

Panel discussion—Q&A session

Discover how NGS can be as quick and easy as immunohistochemistry.

Join on demand